These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 11150898

  • 1. Effect of the repeated administration of (+/-)-3,4-methylenedioxymethamphetamine on the behavioral response of rats to the 5-HT1A receptor agonist (+/-)-8-hydroxy-(di-n-propylamino)tetralin.
    Granoff MI, Ashby CR.
    Neuropsychobiology; 2001 Jan; 43(1):42-8. PubMed ID: 11150898
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure in rats attenuates the effects of a subsequent challenge with MDMA or a 5-hydroxytryptamine(1A) receptor agonist.
    Piper BJ, Vu HL, Safain MG, Oliver AJ, Meyer JS.
    J Pharmacol Exp Ther; 2006 May; 317(2):838-49. PubMed ID: 16434566
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. MDMA stimulus generalization to the 5-HT(1A) serotonin agonist 8-hydroxy-2- (di-n-propylamino)tetralin.
    Glennon RA, Young R.
    Pharmacol Biochem Behav; 2000 Jul; 66(3):483-8. PubMed ID: 10899359
    [Abstract] [Full Text] [Related]

  • 7. MDMA ('Ecstasy') enhances 5-HT1A receptor density and 8-OH-DPAT-induced hypothermia: blockade by drugs preventing 5-hydroxytryptamine depletion.
    Aguirre N, Ballaz S, Lasheras B, Del Río J.
    Eur J Pharmacol; 1998 Apr 10; 346(2-3):181-8. PubMed ID: 9652358
    [Abstract] [Full Text] [Related]

  • 8. Differential induction of 5-HT1A-mediated responses in vivo by three chemically dissimilar 5-HT1A agonists.
    Scott PA, Chou JM, Tang H, Frazer A.
    J Pharmacol Exp Ther; 1994 Jul 10; 270(1):198-208. PubMed ID: 8035316
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Repeated treatment with 8-OH-DPAT induces tolerance to its ability to produce the 5-HT1A behavioural syndrome, but not to its ability to attenuate haloperidol-induced catalepsy.
    Prinssen EP, Koek W, Colpaert FC, Kleven MS.
    Behav Pharmacol; 2000 Jun 10; 11(3-4):299-305. PubMed ID: 11103884
    [Abstract] [Full Text] [Related]

  • 11. The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino)tetralin in the rat.
    Tricklebank MD, Forler C, Fozard JR.
    Eur J Pharmacol; 1984 Nov 13; 106(2):271-82. PubMed ID: 6241568
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The 5-HT1A receptor agonist 8-hydroxy-2-di-n-(propylamino)tetralin (8-OH-DPAT) induces hyperglucagonemia in rats.
    Sugimoto Y, Kimura I, Watanabe Y, Yamada J.
    Biol Pharm Bull; 2001 Oct 13; 24(10):1191-4. PubMed ID: 11642331
    [Abstract] [Full Text] [Related]

  • 14. 50-kHz calls in rats: effects of MDMA and the 5-HT(1A) receptor agonist 8-OH-DPAT.
    Sadananda M, Natusch C, Karrenbauer B, Schwarting RK.
    Pharmacol Biochem Behav; 2012 Apr 13; 101(2):258-64. PubMed ID: 22285322
    [Abstract] [Full Text] [Related]

  • 15. Altered expression of 5-HT1A receptors in adult rats induced by neonatal treatment with clomipramine.
    Limón-Morales O, Soria-Fregozo C, Arteaga-Silva M, Vázquez-Palacios G, Bonilla-Jaime H.
    Physiol Behav; 2014 Jan 30; 124():37-44. PubMed ID: 24211235
    [Abstract] [Full Text] [Related]

  • 16. Some behavioural and neurochemical aspects of subacute (+/-)3,4-methylenedioxymethamphetamine administration in rats.
    McNamara MG, Kelly JP, Leonard BE.
    Pharmacol Biochem Behav; 1995 Nov 30; 52(3):479-84. PubMed ID: 8545462
    [Abstract] [Full Text] [Related]

  • 17. [Behavioural effects of 8-OH-DPAT, a 5-HT1A agonist in rats and effects on the behaviour of antimanic drugs].
    Uchitomi Y, Yamawaki S.
    Yakubutsu Seishin Kodo; 1987 Sep 30; 7(3):383-92. PubMed ID: 2894736
    [Abstract] [Full Text] [Related]

  • 18. Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist.
    Callaway CW, Geyer MA.
    J Pharmacol Exp Ther; 1992 Oct 30; 263(1):318-26. PubMed ID: 1357158
    [Abstract] [Full Text] [Related]

  • 19. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 30; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 20. 5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.
    Bervoets K, Rivet JM, Millan MJ.
    J Pharmacol Exp Ther; 1993 Jan 30; 264(1):95-104. PubMed ID: 8423555
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.